Sinovac Research and Clinical Trials

Company details

Status: Public
HQ: Dhaka, CN
Founded: 2022
Employees: 9
Programs: 115
Drugs: 54
Patents: 0

Official website ↗ All projects Drug pipeline News & analysis

Recent trial activity

8 updates

Latest clinical program signals indexed for Sinovac Research and.

Trial registry

144 studies

NCT00356798
PRO-PanFlu-1001

Phase 1 completed mab

Influenza

CT.gov ↗
NCT00534885
Healive® Lot 1

Approved completed mab

Hepatitis A

CT.gov ↗
NCT00535665
pandemic influenza vaccine (H5N1 strain NIBRG-14)

Phase 2 completed mab

Pandemic Influenza

CT.gov ↗
NCT00556062
seasonal split influenza vaccine

Approved completed mab

Influenza

CT.gov ↗
NCT00660257
pandemic influenza vaccine (H5N1 strain NIBRG-14)

Phase 1 completed mab

Pandemic Influenza Vaccine

CT.gov ↗
NCT00956111
PRO-PanFlu-4001

Approved completed mab

Influenza

CT.gov ↗
NCT01004653
PRO-PanFlu-4001-1

Approved completed mab

Influenza

CT.gov ↗
NCT01008137
H1N1 influenza A Vaccine (PANFLU.1)

Approved completed mab

Influenza

CT.gov ↗
NCT01047202
Pandemic influenza A/H1N1 vaccine

Approved completed mab

Influenza

CT.gov ↗
NCT01252680
Healive+Healive

Approved completed mab

Hepatitis A

CT.gov ↗
NCT01273233
Inactivated Enterovirus Type 71 Vaccine

Phase 1 completed mab

Infection; Viral, Enterovirus

CT.gov ↗
NCT01273246
100U inactivated Enterovirus Type 71 Vaccine

Phase 1 completed mab

Hand-foot-mouth Disease

CT.gov ↗
NCT01421121
100U EV71 vaccine with adjuvant

Phase 2 completed mab

Infection, Viral, Enterovirus

CT.gov ↗
NCT01507857
400U /0.5ml EV71 vaccine

Phase 3 completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT01636245
three consecutive lots of EV71 vaccine

Phase 3 completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT01736709
2012-2013 trivalent seasonal influenza vaccine

Approved completed mab

Influenza

CT.gov ↗
NCT01812135
400 U EV71 vaccine with adjuvant

Phase 2 terminated mab

Infection, Viral, Enterovirus

CT.gov ↗
NCT01865968
Inactivated HAV vaccine

Approved completed mab

Hepatitis A

CT.gov ↗
NCT02269852
trivalent seasonal influenza vaccine

Approved completed mab

Influenza

CT.gov ↗
NCT02445703
Inactivated Hepatitis A vaccine (HAV)

Approved completed mab

Hepatitis A

CT.gov ↗
NCT02451969
Investigational 23-valent PPV

Approved completed mab

Pneumococcal Infections

CT.gov ↗
NCT02692599
Investigational live attenuated mumps vaccine

Phase 3 completed mab

Mumps

CT.gov ↗
NCT02965404
Investigational live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT02981836
Investigational live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT02985320
Single-dose regimen of high dosage investigational sIPV

Phase 2 completed mab

Poliomyelitis

CT.gov ↗
NCT03274102
Concomitant administration of EV71 vaccine with EPI vaccines

Approved completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT03278132
EV71 vaccine

Approved completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT03526978
Investigational sIPV

Phase 3 completed mab

Poliomyelitis

CT.gov ↗
NCT03555071
Vaccine manufactured at commercialized scale

Phase 3 completed mab

Varicella

CT.gov ↗
NCT03822754
sIPV-bOPV-bOPV vaccination schedule

Phase 3 completed mab

Poliomyelitis

CT.gov ↗
NCT03822767
sIPV-sIPV-bOPV vaccination schedule

Phase 3 completed mab

Poliomyelitis

CT.gov ↗
NCT03853993
Quadrivalent influenza vaccine

Phase 3 completed mab

Seasonal Influenza

CT.gov ↗
NCT03859141
Quadrivalent influenza vaccine

Phase 3 completed mab

Seasonal Influenza

CT.gov ↗
NCT03873740
EV71 inactived vaccine（Vero cells）

Approved completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT03903926
5000 volunteers (6-35 months)-EV71 vaccine

Approved completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT03909074
36-71 months old children-experimental EV71 vaccine.

Phase 3 completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT04075201
One dose of investigational vaccine

Phase 1 completed mab

Hepatitis B

CT.gov ↗
NCT04111432
Concomitant administration of EV71vaccine with EPI vaccines

Approved completed mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT04352608
PRO-nCOV-1002

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT04364399
Mumps vaccine

Approved completed mab

Mumps

CT.gov ↗
NCT04383574
PRO-nCOV-1002

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT04386707
PRO-sIPV-3002

Phase 3 completed mab

Poliomyelitis

CT.gov ↗
NCT04456595
Adsorbed COVID-19 (inactivated) Vaccine

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT04508075
SARS-CoV-2 vaccine (inactivated)

Phase 3 completed mab

SARS-CoV2 Infection

CT.gov ↗
NCT04551547
PRO-nCOV-1003

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT04617483
PRO-nCOV-3001

Phase 3 completed mab

Covid19

CT.gov ↗
NCT04618783
PRO-sIPV-1001-1

Unknown completed mab

Poliomyelitis

CT.gov ↗
NCT04651790
SARS-CoV-2 inactivated vaccine

Phase 3 completed mab

Covid19

CT.gov ↗
NCT04801888
PRO-QINF-4001

Approved completed mab

COVID-19

CT.gov ↗
NCT04884685
SARS-CoV-2 Inactivated Vaccine

Approved active mab

COVID-19

CT.gov ↗
NCT04894227
Inactivated SARS-CoV-2 Vaccine (Vero cell）

Approved completed mab

COVID-19

CT.gov ↗
NCT04911790
Experimental Group

Approved completed mab

COVID-19

CT.gov ↗
NCT04953325
Inactivated COVID-19 Vaccine

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT04962308
SARS-CoV-2 Inactivated Vaccine

Approved active mab

COVID-19

CT.gov ↗
NCT04989465
Investigational 23-valent PPV

Approved completed mab

Pneumococcal Infections

CT.gov ↗
NCT04992208
Experimental Group

Approved completed mab

COVID-19

CT.gov ↗
NCT04992260
Inactivated COVID-19 Vaccine

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT04993365
Experimental Group

Approved completed mab

COVID-19

CT.gov ↗
NCT04997239
Two doses of quadrivalent influenza vaccine

Approved completed mab

Seasonal Influenza

CT.gov ↗
NCT05015686
PRO-VZV-4002

Phase 3 active mab

Varicella

CT.gov ↗
NCT05065177
Investigational live attenuated mumps vaccine

Phase 3 completed mab

Mumps

CT.gov ↗
NCT05079217
High-dosage SARS-CoV-2 vaccine

Approved active mab

COVID-19

CT.gov ↗
NCT05092386
Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Phase 1 completed mab

Pneumococcal Infections

CT.gov ↗
NCT05095701
Investigational live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT05107557
Experimental Group

Approved completed mab

COVID-19

CT.gov ↗
NCT05112913
Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

Approved active mab

COVID-19

CT.gov ↗
NCT05137418
COVID-19 Vaccine,Inactivated

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT05150392
Investigational live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT05150496
PRO-nCOV-2002

Phase 2 on hold mab

COVID-19

CT.gov ↗
NCT05156632
Medium-dosage COVID-19 Vaccine,Inactivated

Phase 3 terminated mab

COVID-19

CT.gov ↗
NCT05165732
Experimental vaccine 1

Approved on hold mab

COVID-19

CT.gov ↗
NCT05165966
PRO-nCOV-4010

Approved completed mab

COVID-19

CT.gov ↗
NCT05198336
Inactivated COVID-19 Vaccine

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT05245552
Quadrivalent influenza vaccine(0.25ml)

Phase 3 completed mab

Seasonal Influenza

CT.gov ↗
NCT05254236
PRO-nCOV-2004

Phase 2 terminated mab

COVID-19

CT.gov ↗
NCT05329038
Inactivated COVID-19 Vaccine

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT05381350
PRO-onCOV-3001

Phase 3 completed mab

COVID-19

CT.gov ↗
NCT05386810
Experimental vaccine

Phase 3 completed mab

Poliomyelitis

CT.gov ↗
NCT05397587
Experimental Vaccine

Approved active mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT05398926
COVID-19 Vaccine (Vero cell), Inactivated

Approved completed mab

COVID-19

CT.gov ↗
NCT05411471
PRO-nCOV-2009

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT05431725
PRO-QINF-3004

Phase 3 completed mab

Seasonal Influenza

CT.gov ↗
NCT05432141
sIPV vaccine /DTaP vaccine

Approved completed mab

Poliomyelitis

CT.gov ↗
NCT05433272
PRO-tnCOV-3003

Phase 3 active mab

COVID-19

CT.gov ↗
NCT05460429
Live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT05470855
Live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT05471531
PRO-INF4-MA4002-JStz

Approved completed mab

Influenza and Pneumonia

CT.gov ↗
NCT05477693
Experimental 23-valent PPV

Approved completed mab

Pneumococcal Infections

CT.gov ↗
NCT05494047
Tetravalent influenza vaccine developed by Sinovac Biotech Co.

Phase 3 active small_molecule

Influenza

CT.gov ↗
NCT05499351
Adult group in immunogenicity and safety study of combined immunization

Approved completed mab

COVID-19

CT.gov ↗
NCT05512494
PRO-QINF-4003

Approved completed mab

Seasonal Influenza

CT.gov ↗
NCT05526820
The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

Approved completed mab

Varicella

CT.gov ↗
NCT05593042
CoronaVac®

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT05664919
SA58 Nasal Spray

Unknown active small_molecule

COVID-19

CT.gov ↗
NCT05667714
SA58 Nasal Spray

Unknown active small_molecule

COVID-19

CT.gov ↗
NCT05731115
Experimental 23-valent Pneumococcal

Approved completed mab

Pneumococcal Infections

CT.gov ↗
NCT05850364
Sabin Strain Inactivated Poliovirus Vaccine

Phase 3 completed mab

Poliomyelitis

CT.gov ↗
NCT06042764
SA55 Injection

Phase 2 active small_molecule

Infection of Upper Respiratory Tract Caused by 2019-nCoV

CT.gov ↗
NCT06048393
SA55 nasal spray

Phase 1 active small_molecule

COVID-19

CT.gov ↗
NCT06049927
Quadrivalent influenza vaccine(0.25ml)

Phase 3 completed mab

Seasonal Influenza

CT.gov ↗
NCT06049940
Investigational tetanus vaccine, adsorbed

Phase 3 completed mab

Tetanus

CT.gov ↗
NCT06050460
SA55 Injection

Phase 1 active small_molecule

COVID-19

CT.gov ↗
NCT06058416
PRO-HAV-MA4001-LN

Approved active mab

Hepatitis A

CT.gov ↗
NCT06063057
PRO-EV71/CA16-1001

Phase 2 active mab

Hand, Foot and Mouth Disease

CT.gov ↗
NCT06183216
Sinovac PCV13

Phase 3 active mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT06208683
Mumps vaccine, Live (MV)

Approved active mab

Mumps

CT.gov ↗
NCT06314724
Varicella Vaccine

Phase 3 completed mab

Varicella

CT.gov ↗
NCT06346834
sIPV

Approved active mab

Poliomyelitis

CT.gov ↗
NCT06442449
sIPV

Approved active mab

Poliomyelitis

CT.gov ↗
NCT06474377
Sinovac PCV24 formulation 1

Phase 1 completed mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT06484686
Live attenuated varicella vaccine

Approved active mab

Varicella

CT.gov ↗
NCT06550830
Sinovac PCV24 formulation 1

Phase 1 completed mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT06576024
2 doses of HAV

Approved completed mab

Hepatitis A

CT.gov ↗
NCT06617715
Sinovac PCV13

Phase 3 active mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT06734832
PRO-EV71CA16-3001

Phase 3 active mab

Hand, Foot, and Mouth Disease（HFMD)

CT.gov ↗
NCT06754384
Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)

Phase 2 completed mab

Hand, Foot, and Mouth Disease (HFMD)

CT.gov ↗
NCT06800261
Sinovac PCV24

Phase 2 active mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT06891872
Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

Approved active mab

Varicella (chickenpox)

CT.gov ↗
NCT06939777
SNA02-48

Phase 2 active mab

Tetanus

CT.gov ↗
NCT06950645
Oral hexavalent reassortant rotavirus attenuated live vaccine

Phase 2 active mab

Rotavirus Gastroenteritis

CT.gov ↗
NCT06967272
Oral hexavalent reassortant rotavirus attenuated live vaccine

Phase 2 active mab

Rotavirus Gastroenteritis

CT.gov ↗
NCT06987942
Varicella vaccine+TIV

Approved completed mab

Varicella

CT.gov ↗
NCT06994052
Varicella vaccine

Approved completed mab

VZV

CT.gov ↗
NCT07026500
EV71 Vaccine

Approved completed mab

EV71 Vaccine

CT.gov ↗
NCT07055295
PRO-PVRV-sf-3003

Phase 3 active mab

Rabies

CT.gov ↗
NCT07055880
PRO-PVRV-sf-3003

Phase 3 active mab

Rabies

CT.gov ↗
NCT07055893
Rabies vaccine

Phase 3 active mab

Rabies (Healthy Volunteers)

CT.gov ↗
NCT07211152
Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

Phase 3 active mab

Influenza

CT.gov ↗
NCT07300644
Sinovac PCV24

Phase 2 active mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT07354269
sIPV

Approved active mab

Poliomyelitis

CT.gov ↗
NCT07357545
Sinovac rabies vaccine

Phase 3 active mab

Rabies (Healthy Volunteers)

CT.gov ↗
NCT07374510
high-dose Group ACYW135X Meningococcal Conjugate Vaccine

Phase 1 active mab

Meningococcal Meningitis

CT.gov ↗
NCT07400003
Low-dose experimental vaccine

Phase 2 active mab

Herpes Zoster

CT.gov ↗
NCT07416110
Sinovac rabies vaccine

Phase 3 active mab

Rabies (Healthy Volunteers)

CT.gov ↗
NCT07418229
Low-dose RSV mRNA vaccine

Phase 1 active mab

RSV

CT.gov ↗
NCT07457060
2wIPV+1sIPV

Approved active mab

Poliomyelitis

CT.gov ↗
NCT07473427
Varicella Vaccine

Phase 3 active mab

Varicella (Chickenpox)

CT.gov ↗
NCT07475000
PROVARIX

Phase 3 active mab

Varicella (Chickenpox)

CT.gov ↗
NCT07505810
experimental vaccine

Phase 3 active mab

Epidemic Meningitis

CT.gov ↗
NCT07505823
experimental vaccine

Phase 3 active mab

Epidemic Meningitis

CT.gov ↗
NCT07505836
experimental vaccine

Phase 3 active mab

Epidemic Meningitis

CT.gov ↗
NCT07505888
experimental vaccine

Phase 3 active mab

Epidemic Meningitis

CT.gov ↗
NCT07543198
Sinovac Low-dosage PCV24

Phase 2 completed mab

Pneumococcal Infectious Disease

CT.gov ↗
NCT07593924
Sinovac PCV13

Phase 3 active mab

Pneumococcal Infectious Diseases

CT.gov ↗